Supha Pharmachem Ltd - 539561 - Post- Coc Update
Supha Pharmachem's first Committee of Creditors meeting, held on April 14, 2026, approved the appointment of Raju Mangilal Marshiya as the Resolution Professional. The CoC also ratified IRP remuneration and CIRP expenses, approved the legal advisor, RP's bank account operation, and the estimated budget for the next 6 months. Notably, the suspended directors are not cooperating with the Interim Resolution Professional in handing over control and records.
Apr 17 2026 21:04:00
Supha Pharmachem Ltd - 539561 - Corporate Insolvency Resolution Process (CIRP)-List of Creditors
Supha Pharmachem, under Corporate Insolvency Resolution Process (CIRP) since March 17, 2026, disclosed its list of creditors as of April 6, 2026, with admitted claims totaling ₹82.17 crores. The first Committee of Creditors meeting is set for April 14, 2026, to appoint a Resolution Professional, amidst reported non-cooperation from suspended directors.
Apr 10 2026 18:04:00
Supha Pharmachem Ltd - 539561 - Postponement Of Board Meeting Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Supha Pharmachem Ltd informed that its Board Meeting scheduled for March 30, 2026, to consider Q3 FY26 results, was postponed. This is due to the non-cooperation from suspended directors under the ongoing Corporate Insolvency Resolution Process (CIRP), preventing access to financial information.
Apr 02 2026 18:04:00
Supha Pharmachem Ltd - 539561 - Submission Of Form A - PUBLIC ANNOUNCEMENT
Supha Pharmachem Limited initiated Corporate Insolvency Resolution Process (CIRP) following an NCLT order on March 17, 2026. Public announcement made on March 18, 2026, with Mr. Rajesh Jhunjhunwala appointed as IRP.
Mar 20 2026 22:03:00
Read More